Cambiogenplasmid
From The Right Wiki
Gene therapy | |
---|---|
Target gene | VEGF |
Vector | Plasmid |
Clinical data | |
Trade names | Neovasculgen |
Other names | Pl-VEGF165 |
Routes of administration | Intraneural injection |
ATC code | |
Identifiers | |
CAS Number | |
ChemSpider |
|
Cambiogenplasmid, marketed as Neovasculgen, is a gene therapy drug for treatment of peripheral artery disease, including critical limb ischemia; it delivers the gene encoding for vascular endothelial growth factor (VEGF).[1][2] Neovasculogen is a plasmid encoding the CMV promoter and the 165 amino acid form of VEGF.[3][4] It was developed by the Human Stem Cells Institute in Russia and approved in Russia in 2011.
References
- ↑ "Vascular endothelial growth factor gene therapy - HSCI". Adis Insight. Springer Nature Switzerland AG.
- ↑ "Gene Therapy for PAD Approved". Drug Discovery and Development. 6 December 2011. Archived from the original on 3 September 2015. Retrieved 5 August 2015.
- ↑ "Neovasculogen listing in Eurolab". Eurolab. Retrieved 4 August 2015.
- ↑ Deev RV, Bozo IY, Mzhavanadze ND, Voronov DA, Gavrilenko AV, Chervyakov YV, et al. (September 2015). "pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia". Journal of Cardiovascular Pharmacology and Therapeutics. 20 (5): 473–82. doi:10.1177/1074248415574336. PMID 25770117. S2CID 13443907.
See also
Categories:
- Articles with short description
- Short description with empty Wikidata description
- Use dmy dates from June 2023
- Chemicals that do not have a ChemSpider ID assigned
- Infobox drug articles with non-default infobox title
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a gene therapy
- Approved gene therapies
- All stub articles
- Cardiovascular system drug stubs